7th Feb 2007 07:01
Advanced Medical Solutions Grp PLC07 February 2007 For Immediate Release 7 February 2007 Advanced Medical Solutions Group plc ("AMS" or "the Company") Kimberly-Clark launches InteguSeal* Microbial Sealant in the US Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the globalhealthcare technology company, today announces that a novel application of itsmedical adhesives technology to help reduce the risk of skin flora contaminationthroughout a surgical procedure, a key factor in the development of surgicalsite infections, has been launched in the US. The product was unveiled duringthe annual meeting of the Society of Thoracic Surgery in San Diego, California. Surgical site infections occur in 2-5% of all surgical procedures and they canlead to serious complications and increased morbidity to the patient andsignificant incremental costs to health care providers. In March 2006 AMS announced that it had entered into an exclusive agreement withKimberly-Clark Health Care for the marketing and distribution of InteguSeal*Microbial Sealant in all global markets. The product consists of a film-formingsolution that bonds to the skin sealing off the spaces where bacteria can growand immobilises pathogens to help prevent against migration into a surgicalincision. Easy to apply and fast-drying, InteguSeal* Microbial Sealant can beused with a variety of patient skin preparation treatments and surgical productssuch as electrocautery, sutures, staples and wound adhesives. The versatilefilm bonds to skin surfaces with different curvature, hair-content or amount ortypes of flora present. The product was launched in Europe and other geographies during 2006 and now hasbeen used in more than 15,000 applications during surgical proceduresinternationally. Clearance for sale in the US was granted by the FDA andannounced in October 2006 and following today's announcement, the product hasnow been introduced in the world's largest market for surgical procedures. Atlanta-based Kimberly-Clark Health Care is a business unit with revenues ofmore than $1 billion, within the global Kimberly-Clark Corporation. Itmanufactures and markets a wide range of surgical products and is a leader inseveral medical device categories. Commenting on today's announcement, Dr. Don Evans, Chief Executive of AMS,stated: "I am delighted that InteguSeal* Microbial Sealant has been launched in the US.With its strong presence and focus on the operating room, Kimberly-Clark HealthCare is an ideal marketing and distribution partner for global commercialisationof this technology." -ENDS- For further information, please contact: Advanced Medical Solutions Group plc Tel : +44 (0) 1606 545508Don Evans, Chief ExecutiveMary Tavener, Finance Directorwww.admedsol.com Buchanan Communications Tel: +44 (0) 20 7466 5000Mark Court, Mary-Jane Johnson Notes to Editors: Advanced Medical Solutions is a leading company in the development andmanufacture of products for the $13 billion global woundcare market. Founded in 1991 and currently quoted on AIM, Advanced Medical Solutions isfocused on the design, development and manufacture of innovative andtechnologically advanced products for woundcare and other medical applications. In-house natural and synthetic polymer technology is used to provide advancedwound dressings based on the moist healing principle. AMS's resources ensure aunique position as a vertically integrated 'one stop shop' to provide allcategories of moist wound healing products. The Company has the capability tomove from product design and development through to production and deliveryready for distribution into customer markets. The acquisition of MedLogic in 2002 has brought AMS products and technology incyanoacrylate based tissue adhesives that offer benefits over sutures andstaples for closing wounds sold direct to hospitals or through distributors. AMS's technology and products currently serve the majority of the key globalmarkets and strategic partners. Kimberly-Clark in the Healthcare Environment Around the world, medical professionals turn to Kimberly-Clark for a wideportfolio of solutions that improve the health, hygiene and well-being of theirpatients and staff. As part of their healing mission, caregivers rely onKimberly-Clark to deliver clinical solutions and educational resources that theycan depend on to prevent, diagnose and manage a wide variety ofhealthcare-associated infections. This over $1 billion global enterprise ofKimberly-Clark Corporation holds the No. 1 and No. 2 market share positions inseveral categories including infection control solutions, surgical solutions,pain management and digestive health. And throughout the care continuum,patients and staff alike trust Kimberly-Clark* medical supplies and devices,KLEENEX(R) tissues, Kimberly-Clark* professional skin care products, and SCOTT(R) towels for day-to-day needs. For more information, please visit http://www.kchealthcare.com. (R)Registered Trademark or * Trademark of Kimberly-Clark Worldwide, Inc. (c)2007 KCWW. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Advanced Medical Solutions Group